Insider Profile
Raghubir, Sharan
1
Companies Filed At
1
Open-Market Buys (2yr)
$28K
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
| Date | Company | Dir. | Value |
|---|---|---|---|
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Buy | $31K |
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Sell | — |
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Buy | — |
| Jun 30, 2026 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2026 |
$RX
BioSyent Inc.
|
Sell | — |
| Mar 31, 2026 |
$RX
BioSyent Inc.
|
Buy | $31K |
| Mar 31, 2025 |
$RX
BioSyent Inc.
|
Sell | — |
| Mar 31, 2025 |
$RX
BioSyent Inc.
|
Buy | $19K |
| Mar 28, 2025 |
$RX
BioSyent Inc.
|
Buy | $28K |
| Mar 28, 2025 |
$RX
BioSyent Inc.
|
Buy | $28K |
| Mar 28, 2025 |
$RX
BioSyent Inc.
|
Sell | $8K |
| Dec 17, 2024 |
$RX
BioSyent Inc.
|
Sell | $21K |
| Dec 16, 2024 |
$RX
BioSyent Inc.
|
Sell | $33K |
| Jun 20, 2024 |
$RX
BioSyent Inc.
|
Buy | $19K |
| Jun 20, 2024 |
$RX
BioSyent Inc.
|
Buy | $19K |
| Jun 20, 2024 |
$RX
BioSyent Inc.
|
Buy | $18K |
| Mar 27, 2024 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Sell | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Mar 31, 2023 |
$RX
BioSyent Inc.
|
Buy | — |
| Dec 31, 2022 |
$RX
BioSyent Inc.
|
Buy | $570 |
| Dec 31, 2022 |
$RX
BioSyent Inc.
|
Buy | $7K |
| Mar 31, 2022 |
$RX
BioSyent Inc.
|
Buy | $30K |
| Mar 29, 2022 |
$RX
BioSyent Inc.
|
Sell | $16K |
| Mar 29, 2022 |
$RX
BioSyent Inc.
|
Sell | $9K |
| Mar 29, 2022 |
$RX
BioSyent Inc.
|
Sell | $8K |
| Mar 29, 2022 |
$RX
BioSyent Inc.
|
Sell | $9K |
| Mar 24, 2022 |
$RX
BioSyent Inc.
|
Buy | $40K |
| Mar 21, 2022 |
$RX
BioSyent Inc.
|
Buy | $5K |
| Mar 18, 2022 |
$RX
BioSyent Inc.
|
Buy | $69K |
| Dec 31, 2021 |
$RX
BioSyent Inc.
|
Buy | $5K |
| Mar 19, 2021 |
$RX
BioSyent Inc.
|
Buy | $29K |
| Dec 31, 2020 |
$RX
BioSyent Inc.
|
Buy | $2K |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Confluence Scores reflect the company's current score, not the score at time of trade.